Switch theme
Sign up to access all valuation multiples
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
2002
3.1K+
LTM Revenue $1.2B
LTM EBITDA $484M
$8.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
HealthEquity has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $484M.
In the most recent fiscal year, HealthEquity achieved revenue of $1.2B and an EBITDA of $339M.
HealthEquity expects next 12-month revenue of XXX and NTM EBITDA of XXX
See HealthEquity valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $862M | $1000M | XXX | XXX | XXX |
| Gross Profit | $490M | $623M | XXX | XXX | XXX |
| Gross Margin | 57% | 62% | XXX | XXX | XXX |
| EBITDA | $172M | $284M | XXX | XXX | XXX |
| EBITDA Margin | 20% | 28% | XXX | XXX | XXX |
| Net Profit | -$26.1M | $55.7M | XXX | XXX | XXX |
| Net Margin | -3% | 6% | XXX | XXX | XXX |
| Net Debt | $671M | $471M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, HealthEquity's stock price is $83.
HealthEquity has current market cap of $7.2B, and EV of $8.0B.
See HealthEquity trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.0B | $7.2B | XXX | XXX | XXX | XXX | $3.22 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, HealthEquity has market cap of $7.2B and EV of $8.0B.
HealthEquity's trades at 6.6x LTM EV/Revenue multiple, and 16.6x LTM EBITDA.
Analysts estimate HealthEquity's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for HealthEquity and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $8.0B | XXX | XXX | XXX |
| EV/Revenue | 6.8x | XXX | XXX | XXX |
| EV/EBITDA | 24.0x | XXX | XXX | XXX |
| P/E | 77.3x | XXX | XXX | XXX |
| P/E/Growth | 1.4x | XXX | XXX | XXX |
| EV/FCF | -59.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHealthEquity's NTM/LTM revenue growth is 9%
HealthEquity's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, HealthEquity's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate HealthEquity's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for HealthEquity and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 65% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 37% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 20% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 48% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Star Health Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| Hapvida | XXX | XXX | XXX | XXX | XXX | XXX |
| Qualicorp | XXX | XXX | XXX | XXX | XXX | XXX |
| Accolade | XXX | XXX | XXX | XXX | XXX | XXX |
| AIX Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HealthEquity acquired XXX companies to date.
Last acquisition by HealthEquity was XXXXXXXX, XXXXX XXXXX XXXXXX . HealthEquity acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was HealthEquity founded? | HealthEquity was founded in 2002. |
| Where is HealthEquity headquartered? | HealthEquity is headquartered in United States of America. |
| How many employees does HealthEquity have? | As of today, HealthEquity has 3.1K+ employees. |
| Who is the CEO of HealthEquity? | HealthEquity's CEO is Mr. Scott R. Cutler. |
| Is HealthEquity publicy listed? | Yes, HealthEquity is a public company listed on NAS. |
| What is the stock symbol of HealthEquity? | HealthEquity trades under HQY ticker. |
| When did HealthEquity go public? | HealthEquity went public in 2014. |
| Who are competitors of HealthEquity? | Similar companies to HealthEquity include e.g. Star Health Insurance, Hapvida, Qualicorp, Accolade. |
| What is the current market cap of HealthEquity? | HealthEquity's current market cap is $7.2B |
| What is the current revenue of HealthEquity? | HealthEquity's last 12-month revenue is $1.2B. |
| What is the current EBITDA of HealthEquity? | HealthEquity's last 12-month EBITDA is $484M. |
| What is the current EV/Revenue multiple of HealthEquity? | Current revenue multiple of HealthEquity is 6.6x. |
| What is the current EV/EBITDA multiple of HealthEquity? | Current EBITDA multiple of HealthEquity is 16.6x. |
| What is the current revenue growth of HealthEquity? | HealthEquity revenue growth between 2023 and 2024 was 16%. |
| Is HealthEquity profitable? | Yes, HealthEquity is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
